Clinical Trial Update: MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MammoSite as the sole radiation therapy technique for ductal carcinoma in situ; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ

Drugs mentioned

• Mammosite

Snippet

Sponsor: Hologic, Inc. | Conditions: DCIS | Phase 2 | Status: COMPLETED | Results posted: 2012-10-22